美股市場個股詳情
DXCM 德康醫療
- 128.370
- +1.720+1.36%
收盤價 05/03 16:00 (美東)
- 128.600
- +0.230+0.18%
盤後 19:46 (美東)
510.51億總市值83.36市盈率TTM
129.220最高價126.910最低價177.90萬股成交量127.220今開126.650昨收2.28億成交額0.45%換手率98.75市盈率(靜)3.98億總股本142.00052周最高22.72市淨率503.06億流通值74.75052周最低--股息TTM3.92億流通股164.863歷史最高--股息率TTM1.82%振幅0.340歷史最低128.424平均價1股每手
關於德康醫療公司
德康醫療公司爲糖尿病患者設計並商業化連續血糖監測（CGM）系統。連續血糖監測系統可作爲傳統血糖儀工藝的替代方案，該公司正在發展其連續血糖監測系統，以提供與胰島素泵的集成，以實現胰島素的自動輸送。
公司介紹
公司代碼DXCM
公司名稱德康醫療
上市日期2005/04/14
發行價格12.00
成立日期1999
所屬市場納斯達克
員工數量9600
證券類型海外普通股
年結日12-31
公司地址6340 Sequence Drive
城市San Diego
省份加利福尼亞州
國家美國
郵編92121
電話1-858-200-0200
董事高管
- 姓名
- 職務
- 年薪
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 1571.22萬
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 434.28萬
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 493.80萬
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 652.66萬
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 425.49萬
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 34.65萬
- Kyle Malady
- Independent Director
- 34.34萬
- Dr. Barbara E. Kahn
- Independent Director
- 34.84萬
- Karen M. Dahut
- Independent Director
- 34.59萬
- Rimma Driscoll
- Independent Director
- 40.47萬
- Nicholas Augustinos
- Independent Director
- 36.22萬
- Steven R. Altman
- Independent Director
- 34.34萬
- Bridgette P. Heller
- Independent Director
- 34.65萬
- Richard A. Collins
- Independent Director
- 34.59萬
- Mark G. Foletta
- Lead Independent Director
- 39.35萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
